Newsroom | 2836 results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026 first quarter ended December 31, 2025, revenue increased 5.5 percent year-over-year to $85.9 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.87 for the first quarter of fiscal 2026 compared to $2.50 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described below,...

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on March 25, 2026, to stockholders of record at the close of business on March 4, 2026. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with liv...

AUSTIN, Texas--(BUSINESS WIRE)--VMD Sciences, the leader in global veterinary pharmaceutical access services, announced the successful, compliant importation by a U.S. licensed veterinarian of an advanced cancer therapy approved in Europe. The specialized tyrosine kinase inhibitor unavailable in the U.S. was for the treatment of Jetta, an 8-year-old mixed-breed dog battling metastatic mast cell cancer. Through their Managed Access Program (MAP), VMD Sciences supported Dr. Seth Glasser, DVM, Dip...

NEW YORK--(BUSINESS WIRE)--BARK, Inc. (NYSE: BARK) (“BARK” or the “Company”), a leading global omnichannel dog brand with a mission to make all dogs happy, today announced that the special committee (the “Special Committee”) of the Company’s Board of Directors has retained Moelis & Company LLC as financial advisor and Sidley Austin LLP as legal advisor to assist the Special Committee in the review and evaluation of the previously disclosed preliminary non-binding indicative proposal letters...

NEW YORK--(BUSINESS WIRE)--BARK (NYSE: BARK), a leading global omnichannel dog brand on a mission to make all dogs happy, today announced the launch of Who’s A Good Guest?, a new video series hosted by entertainment journalist Josh Horowitz, produced by BARK and Horowitz. Season one features a star-studded lineup of dog parents, including Zoey Deutch, Dylan O’Brien, Bob Odenkirk, Johnny Knoxville, Ginnifer Goodwin, and Patrick Wilson. The first episode, featuring O’Brien and his dog Tony, debut...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. Fourth Quarter and Full Year Results The Company reports revenues of $1,091 million for the fourth quarter of 2025, an increase of 14% compared to the prior year period as reported and 12% on an organic basis, driven by Companion Animal Group ("CAG") growth of 15% as reported and 13% organic and Water revenue growth of 12...

LAS VEGAS--(BUSINESS WIRE)--Gilad&Gilad launches AgmaVet® For Horses containing the neuroprotective ingredient G-Agmatine® for resilient nerve functions and joints mobility....

LONDON--(BUSINESS WIRE)--Automata, the lab automation company building fully integrated, AI-ready platforms for life sciences, today announced the close of a $45 million Series C funding round led by Dimension with participation from Danaher Ventures, Tru Arrow Partners, Octopus Ventures, Entrepreneurs First, and others. The round also includes a strategic investment partnership with Danaher Corporation, with Murali Venkatesan Ph.D., Global Head of Danaher Ventures and Vice President of Science...

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following...

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its second quarter financial results on Wednesday, February 4, 2026, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 5, 2026, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (8...